BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 22/09/2025

Elon Musk's Neuralink to Begin Human Trials in 2024

Neuralink, a neurotechnology company founded by Elon Musk, plans to begin human trials for its brain-machine interface technology in 2024, with the goal of treating medical conditions such as paralysis and depression.

Source: Federal Register — All DocumentsOpen original release →